An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Biomedical research impacts all of us. I became curious about how drugs work after my mom was diagnosed with rheumatoid arthritis when I was a small boy. She received “gold shots” as treatment, which ...

Japanese drugmaker Kyowa Kirin and Swiss generics and biosimilars giant Sandoz have won approval for the partial change of their rituximab biosimilar for the treatment of refractory nephrotic syndrome ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, reviewed how outcomes have changed in patients with primary ...

Today, Benzinga 's options scanner spotted 32 uncommon options trades for Biogen. This isn't normal. The overall sentiment of these big-money traders is split between 37% bullish and 31%, bearish. Out ...

Some laboratory research has investigated the potential action of rituximab (Rituxan), a cancer drug that targets certain cells in the immune system, for treating ME/CFS. However, more research is ...

Roche is looking for new revenues as its “big three” blockbuster cancer drugs Avastin, Herceptin, and Rituxan/MabThera lose their patent protection and face competition from cheaper near-copy ...

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology ...

With an additional 15 predicted by 2023, Roche is set fair to weather the 'patent cliff' it is facing with drugs like Avastin (bevacizumab), Herceptin (trastuzumab) and MabThera/Rituxan (rituximab ...